These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38518294)

  • 21. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.
    Miller KC; Marinelli JP; Van Gompel JJ; Link MJ; Janus JR; Foote RL; Price KA; Garcia J; Rivera M; Chintakuntlawar AV
    Head Neck; 2019 May; 41(5):1335-1341. PubMed ID: 30536472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfaction Preservation and Long-Term Outcomes in Patients with Unilateral Endoscopic Resection of Olfactory Neuroblastoma: A Systematic Review and Institutional Experience.
    Rodas A; Tariciotti L; Zohdy YM; Soriano RM; Daoud GE; Porto E; Vuncannon JR; Revuelta-Barbero JM; Garzon-Muvdi T; McDonald M; Pradilla G; Wise SK; Barrow E; Solares CA; DelGaudio JM
    World Neurosurg; 2024 Oct; 190():e874-e882. PubMed ID: 39127371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database.
    Duo GS; Feng JL; Zhang ZY; Wang LJ
    Cancer Radiother; 2022 Sep; 26(5):663-669. PubMed ID: 35249817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.
    Hanna E; DeMonte F; Ibrahim S; Roberts D; Levine N; Kupferman M
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1219-24. PubMed ID: 20026819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.
    Mizumoto M; Furukawa T; Yui M; Iritani K; Tatehara S; Inokuchi G; Teshima M; Shinomiya H; Kimura H; Kiyota N; Sasaki R; Nibu KI
    Kobe J Med Sci; 2024 Jun; 70(2):E56-E60. PubMed ID: 38936878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prognostic Implications of Neutrophil-to-Lymphocyte Ratio in Olfactory Neuroblastoma.
    Mocharnuk J; Daniels KE; Filimonov A; North LM; Gardner PA; Wang EW; Snyderman CH
    Otolaryngol Head Neck Surg; 2024 Oct; 171(4):1212-1216. PubMed ID: 38895868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endonasal endoscopic resection of olfactory neuroblastoma: an 11-year experience.
    Gallia GL; Asemota AO; Blitz AM; Lane AP; Koch W; Reh DD; Ishii M
    J Neurosurg; 2019 Jul; 131(1):238-244. PubMed ID: 30074458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
    Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
    World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory neuroblastoma limited to sphenoid sinus.
    Kumaria A; Jahshan F; Paine S; Reed M; Ingale HA; Ramakrishnan Y
    Br J Neurosurg; 2023 Apr; 37(2):237-240. PubMed ID: 35174758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
    Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature.
    Abdelmeguid AS; Bell D; Roberts D; Ferrarotto R; Phan J; Su SY; Kupferman M; Raza S; DeMonte F; Hanna E
    Laryngoscope; 2022 Feb; 132(2):290-297. PubMed ID: 34272876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of long-term outcomes for patients with esthesioneuroblastoma.
    Ow TJ; Hanna EY; Roberts DB; Levine NB; El-Naggar AK; Rosenthal DI; DeMonte F; Kupferman ME
    Head Neck; 2014 Apr; 36(4):524-30. PubMed ID: 23780581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esthesioneuroblastoma: the role of adjuvant radiation therapy.
    Foote RL; Morita A; Ebersold MJ; Olsen KD; Lewis JE; Quast LM; Ferguson JA; O'Fallon WM
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):835-42. PubMed ID: 8244813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery as Single-Modality Treatment for Early-Stage Olfactory Neuroblastoma: An Institutional Experience, Systematic Review and Meta-analysis.
    Meerwein CM; Nikolaou G; H A Binz G; Soyka MB; Holzmann D
    Am J Rhinol Allergy; 2021 Jul; 35(4):525-534. PubMed ID: 33174762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma.
    Kaur G; Kane AJ; Sughrue ME; Madden M; Oh MC; Sun MZ; Safaee M; El-Sayed I; Aghi M; McDermott MW; Berger MS; Parsa AT
    J Clin Neurosci; 2013 Feb; 20(2):281-6. PubMed ID: 23266076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of regional and distant metastasis in esthesioneuroblastoma.
    Banuchi VE; Dooley L; Lee NY; Pfister DG; McBride S; Riaz N; Bilsky MH; Ganly I; Shah JP; Kraus DH; Morris LG
    Laryngoscope; 2016 Jul; 126(7):1556-61. PubMed ID: 26865537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.